Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.

Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, Lin H, Xiao L, Maguy A, Qi XY, Li Y, Gao X, Dong D, Zhang Y, Bai Y, Ai J, Sun L, Lu H, Luo XY, Wang Z, Lu Y, Yang B, Nattel S.

J Clin Invest. 2013 May;123(5):1939-51. doi: 10.1172/JCI62185. Epub 2013 Apr 1.

2.

Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling.

Qi XY, Huang H, Ordog B, Luo X, Naud P, Sun Y, Wu CT, Dawson K, Tadevosyan A, Chen Y, Harada M, Dobrev D, Nattel S.

Circ Res. 2015 Feb 27;116(5):836-45. doi: 10.1161/CIRCRESAHA.116.305326. Epub 2015 Jan 21.

3.

Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation.

Ling TY, Wang XL, Chai Q, Lau TW, Koestler CM, Park SJ, Daly RC, Greason KL, Jen J, Wu LQ, Shen WF, Shen WK, Cha YM, Lee HC.

Heart Rhythm. 2013 Jul;10(7):1001-9. doi: 10.1016/j.hrthm.2013.03.005. Epub 2013 Mar 14.

4.

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.

Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR.

Heart Rhythm. 2009 Dec;6(12):1802-9. doi: 10.1016/j.hrthm.2009.08.035. Epub 2009 Sep 3.

PMID:
19959133
6.

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.

Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, Zhang Y, Shan H, Luo X, Bai Y, Sun L, Song W, Xu C, Wang Z, Yang B.

Circulation. 2010 Dec 7;122(23):2378-87. doi: 10.1161/CIRCULATIONAHA.110.958967. Epub 2010 Nov 22. Erratum in: Circulation. 2011 Sep 20;124(12):e334.

7.
8.

Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation.

Harada M, Luo X, Qi XY, Tadevosyan A, Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, Shi Y, Kamiya K, Murohara T, Kodama I, Tardif JC, Schotten U, Van Wagoner DR, Dobrev D, Nattel S.

Circulation. 2012 Oct 23;126(17):2051-64. doi: 10.1161/CIRCULATIONAHA.112.121830. Epub 2012 Sep 19.

9.

A novel dual-fluorescence strategy for functionally validating microRNA targets in 3' untranslated regions: regulation of the inward rectifier potassium channel K(ir)2.1 by miR-212.

Goldoni D, Yarham JM, McGahon MK, O'Connor A, Guduric-Fuchs J, Edgar K, McDonald DM, Simpson DA, Collins A.

Biochem J. 2012 Nov 15;448(1):103-13. doi: 10.1042/BJ20120578.

10.

Inward rectifier potassium currents as a target for atrial fibrillation therapy.

Ehrlich JR.

J Cardiovasc Pharmacol. 2008 Aug;52(2):129-35. doi: 10.1097/FJC.0b013e31816c4325. Review.

PMID:
18670367
11.

Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.

Kharche S, Garratt CJ, Boyett MR, Inada S, Holden AV, Hancox JC, Zhang H.

Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):186-97. doi: 10.1016/j.pbiomolbio.2008.10.010. Epub 2008 Nov 9.

PMID:
19041665
12.

Experimental study on inhibition of rat ventricular Ik1 by RNA interference targeting the KCNJ2 gene.

Hu B, Zhu XL, Fan QX, Li HX, Zou CW.

Biosci Trends. 2012 Feb;6(1):26-32. doi: 10.5582/bst.2012.v6.1.26.

13.

A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.

Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M, Kimura T.

Cardiovasc Res. 2012 Mar 15;93(4):666-73. doi: 10.1093/cvr/cvr329. Epub 2011 Dec 8.

14.

Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.

Voigt N, Trausch A, Knaut M, Matschke K, Varró A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D.

Circ Arrhythm Electrophysiol. 2010 Oct;3(5):472-80. doi: 10.1161/CIRCEP.110.954636. Epub 2010 Jul 24.

15.

KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.

Deo M, Ruan Y, Pandit SV, Shah K, Berenfeld O, Blaufox A, Cerrone M, Noujaim SF, Denegri M, Jalife J, Priori SG.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4291-6. doi: 10.1073/pnas.1218154110. Epub 2013 Feb 25.

16.

Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation.

Dobrev D, Wettwer E, Kortner A, Knaut M, Schüler S, Ravens U.

Cardiovasc Res. 2002 May;54(2):397-404.

17.

A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation.

Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J, Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings P, Barhanin J, Chen Y.

Biochem Biophys Res Commun. 2005 Jul 15;332(4):1012-9.

PMID:
15922306
18.

Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes.

Saygili E, Rana OR, Saygili E, Reuter H, Frank K, Schwinger RH, Müller-Ehmsen J, Zobel C.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2898-905. Epub 2007 Feb 9.

19.

Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.

Lange PS, Er F, Gassanov N, Hoppe UC.

Cardiovasc Res. 2003 Aug 1;59(2):321-7.

20.

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

Cardin S, Guasch E, Luo X, Naud P, Le Quang K, Shi Y, Tardif JC, Comtois P, Nattel S.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1027-35. doi: 10.1161/CIRCEP.112.973214. Epub 2012 Aug 26.

Items per page

Supplemental Content

Write to the Help Desk